Showing results (141-150 of 230) with videos related to
Sort By:
Pageof 23
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failureJames G Douglas, Keith J Stelzer, David A Mankoff, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapyAjay K Gopal, John M Pagel, Joseph G Rajendran, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2019
PennPET Explorer: Human Imaging on a Whole-Body ImagerAustin R Pantel, Varsha Viswanath, Margaret E Daube-Witherspoon, et al.Nature Biomedical Engineering|July 22, 2026
CLEAR: an auditable foundation model for radiology grounded in clinical conceptsTianyu Han, Riga Wu, Yu Tian, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Influence of Subcellular Localization on the Cytotoxicity of Targeted α-TherapyHwan Lee, Swarbhanu Sarkar, Kexiang Xu, et al.Radiology. Imaging Cancer|January 28, 2022
The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1Hsiaoju S Lee, Sally W Schwarz, Erin K Schubert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcomeAlexander M Spence, Mark Muzi, Michael M Graham, et al.Breast Cancer Research and Treatment|February 3, 2007
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)Jennifer M Specht, Stephen L Tam, Brenda F Kurland, et al.Clinical Nuclear Medicine|June 6, 2025
Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity by ImmunohistochemistryIsmaheel O Lawal, Xiaoxian Li, Elizabeth A Sakach, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalationKevin S Tralins, James G Douglas, Keith J Stelzer, et al.Pageof 23